EUVIMEDEUVIMED entdecken
Open Access

Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple negative breast cancer treated with neoadjuvant chemotherapy

Gabriel Berlingieri Polho, Leticia Kimie Murazawa, Vinicius Vitor Oliveira, Victor Rocha Pinheiro, Diana Del Cisne Pineda Labanda, Yumi Ricucci Shinkado, Romualdo Barroso-Sousa, Luciana Rodrigues Carvalho Barros, Laura Testa, Renata Colombo Bonadio

ecancermedicalscience · 14.11.2025 · 19

DOI: 10.3332/ecancer.2025.2034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ecancermedicalscience, online erschienen am 14.11.2025. Verfasst von Gabriel Berlingieri Polho und 9 weiteren Autor:innen. Beteiligte Einrichtung: Instituto do Câncer do Estado de São Paulo, Av Dr Arnaldo, 251 - Cerqueira Cesar, São Paulo, SP 01246-000, Brazil. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Biomarkers for tailoring treatment in neoadjuvant triple-negative breast cancer (TNBC) are needed. We hypothesize that neutrophil-to-lymphocyte ratio (NLR) before neoadjuvant chemotherapy (NACT) can predict long-term outcomes in this population.

Methods

We reviewed our institutional database to identify patients with clinical stages II-III TNBC who underwent NACT from 2012 to 2024 and retrospectively collected data from medical records. We calculated event-free survival (EFS) from the date of NACT initiation until death, disease recurrence or disease progression that precluded surgery; we calculated overall survival (OS) from the date of NACT initiation until death. Survival estimates were analysed using Kaplan-Meier method and compared with log rank test. The Cox regression model was used to calculate hazard ratios.

Results

A total of 692 patients were included in the analysis. Of these, 63.3% had stage III disease, 60.8% had grade 3 tumours and 77.2% had a Ki-67 >50%. The most common NACT regimen used was anthracycline and taxane-based (96.8%). The overall pathological complete response (pCR) rate was 27.7%. After median follow-up of 59.6 months, NLR >2 was associated with poorer EFS (HR 1.71, 95% CI 1.33-2.18, p < 0.001) and OS (HR 1.76, 95% CI 1.34-2.31, p < 0.001). The results maintained statistical significance after adjusting for age, ki67, clinical stage and pCR status (p = 0.002).

Conclusion

NLR predicts long-term survival after NACT in TNBC and, as a readily and inexpensive information, should be further studied in current approaches of chemoimmunotherapy.

Schlagwörter

Stichwörter der Autor:innen

breast cancerneoadjuvantneutrophil-to-lymphocyte ratiotriple-negative

Autor:innen und Institutionen

  • Instituto do Câncer do Estado de São Paulo, Av Dr Arnaldo, 251 - Cerqueira Cesar, São Paulo, SP 01246-000, Brazil.
  • Dasa Oncology, Brasilia Hospital, SHIS QI 15 - Lago Sul, Brasília 71635-240, Brazil.
  • Instituto D'Or de Pesquisa e Ensino (IDOR), Av Brigadeiro Luís Antônio, 5001 - Jardim Paulista, São Paulo, SP 22281-100, Brazil.
  • https://orcid.org/0000-0001-5818-922X.

Zitieren

APA

Polho, G. B., Murazawa, L. K., Oliveira, V. V., Pinheiro, V. R., Del Cisne Pineda Labanda, D., Shinkado, Y. R., Barroso-Sousa, R., Barros, L. R. C., Testa, L., & Bonadio, R. C. (2025). Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple negative breast cancer treated with neoadjuvant chemotherapy. ecancermedicalscience, 19. https://doi.org/10.3332/ecancer.2025.2034

Vancouver

Polho GB, Murazawa LK, Oliveira VV, Pinheiro VR, Del Cisne Pineda Labanda D, Shinkado YR, et al. Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple negative breast cancer treated with neoadjuvant chemotherapy. ecancermedicalscience. 2025;19. doi:10.3332/ecancer.2025.2034

BibTeX
@article{Polho2025,
  author = {Polho, Gabriel Berlingieri and Murazawa, Leticia Kimie and Oliveira, Vinicius Vitor and Pinheiro, Victor Rocha and Del Cisne Pineda Labanda, Diana and Shinkado, Yumi Ricucci and Barroso-Sousa, Romualdo and Barros, Luciana Rodrigues Carvalho and Testa, Laura and Bonadio, Renata Colombo},
  title = {Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple negative breast cancer treated with neoadjuvant chemotherapy},
  journal = {ecancermedicalscience},
  year = {2025},
  volume = {19},
  doi = {10.3332/ecancer.2025.2034}
}
Kostenlos starten →